Effectiveness and tolerability of perampanel as first add-on treatment in pediatric patients with focal and generalized epilepsy
The improved effectiveness outcomes of perampanel used as first vs. late add-on therapy in a pediatric population and the favorable safety outcomes support its use as first add-on therapy in pediatric patients with focal and generalized epilepsy.
Authors
- Beatriz Muñoz Cabello (ORCID: https://orcid.org/0000-0002-7211-8804)
- Marta Correa Vela
- Mercedes López Lobato
- Olga Alonso Luengo
- Carmen Diéguez Jiménez
- Elena Arce Portillo
- Bárbara Blanco Martínez
- M.Á. Cabeza (ORCID: https://orcid.org/0000-0002-5368-7622)
- L. González Hernández
Institutions
- Hospital Universitario Virgen del Rocío (ES)
Publication Details
- Journal
- Epilepsy Research
- Published
- 2025-10-24
- DOI
- https://doi.org/10.1016/j.eplepsyres.2025.107690
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00